Electroclinical Improvement in a Patient with Ring Chromosome 20 Syndrome Treated with Zonisamide: A Case Report

J Pediatr Genet. 2021 Apr 1;12(3):219-223. doi: 10.1055/s-0041-1726281. eCollection 2023 Sep.

Abstract

Ring chromosome 20 or r(20) syndrome is a rare chromosomal disorder, mainly characterized by childhood-onset drug-resistant epilepsy with typical electroencephalographic findings, followed by mild to severe cognitive-behavioral decline. Recent studies support a possible role of the dopaminergic system in the epileptogenesis of this syndrome. We report the case of a 13-year-old female with mosaic r(20) who showed typical disease onset and evolution and a remarkable electroclinical improvement with zonisamide. Epilepsy related to r(20) is often medically intractable. When valproate and lamotrigine are not effective, zonisamide could be further investigated as a therapeutic option, since it acts as antifocal and it has a potential role in the prevention of dopamine depletion.

Keywords: dopamine; drug-resistant epilepsy; ring chromosome 20.

Publication types

  • Case Reports

Grants and funding

Funding This work was partially supported by Italian Ministry of Health (RC 2020–2022).